Showing 1 - 20 results of 25 for search 'S Papapoulos', query time: 0.04s
Refine Results
-
1
Osteocytic sclerostin expression is locally reduced at the site of femoral neck fracture by Power, J, Parker, M, Papapoulos, S, van Bezooijen, R, Reeve, J, Loveridge, N
Published 2011Journal article -
2
Selerostin is a delayed secreted product of osteocytes that regulates BMU width and cortical canal infilling by Poole, K, Van Bezooijen, R, Loveridge, N, Papapoulos, SE, Lowik, C, Reeve, J
Published 2005Journal article -
3
Sclerostin expression by osteocytes is a delayed event; Implications for the control of bone formation by Poole, K, Van Bezooijen, R, Loveridge, N, Papapoulos, SE, Lowik, C, Reeve, J
Published 2005Journal article -
4
Similarities and Differences in the Management of Patients with Osteoporotic Vertebral Fractures and Those with Rebound-Associated Vertebral Fractures Following Discontinuation of... by Athanasios D. Anastasilakis, Polyzois Makras, Julien Paccou, Ilias Bisbinas, Stergios A. Polyzos, Socrates E. Papapoulos
Published 2023-09-01
Article -
5
Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International... by Rizzoli, R, Akesson, K, Bouxsein, M, Kanis, J, Napoli, N, Papapoulos, S, Reginster, J, Cooper, C
Published 2011Journal article -
6
Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation. by Poole, K, van Bezooijen, R, Loveridge, N, Hamersma, H, Papapoulos, SE, Löwik, C, Reeve, J
Published 2005Journal article -
7
Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International... by Rizzoli, R, Akesson, K, Bouxsein, M, Kanis, J, Napoli, N, Papapoulos, S, Reginster, J, Cooper, C
Published 2011Journal article -
8
-
9
-
10
-
11
-
12
Osteocyte sclerostin expression: Regulator of BMU balance in osteoarthritis and osteoporosis? by Loveridge, N, Power, J, Caballero-Alias, A, van Bezooijen, R, Papapoulos, S, Lowik, C, Poole, K, Reeve, J
Published 2007Conference item -
13
-
14
-
15
Sclerostin and the regulation of bone formation: Effects in hip osteoarthritis and femoral neck fracture. by Power, J, Poole, K, van Bezooijen, R, Doube, M, Caballero-Alías, A, Lowik, C, Papapoulos, S, Reeve, J, Loveridge, N
Published 2010Journal article -
16
Ibandronate for the prevention of nonvertebral fractures: a pooled analysis of individual patient data. by Cranney, A, Wells, G, Yetisir, E, Adami, S, Cooper, C, Delmas, P, Miller, P, Papapoulos, S, Reginster, J, Sambrook, P, Silverman, S, Siris, E, Adachi, J
Published 2009Journal article -
17
Nasal Levels of Antimicrobial Peptides in Allergic Asthma Patients and Healthy Controls: Differences and Effect of a Short 1,25(OH)2 Vitamin D3 Treatment. by Willemien Thijs, Kirsten Janssen, Annemarie M van Schadewijk, Socrates E Papapoulos, Saskia le Cessie, Saskia Middeldorp, Christian F Melissant, Klaus F Rabe, Pieter S Hiemstra
Published 2015-01-01
Article -
18
Management of glucocorticoid-induced osteoporosis. by Rizzoli, R, Adachi, J, Cooper, C, Dere, W, Devogelaer, J, Diez-Perez, A, Kanis, J, Laslop, A, Mitlak, B, Papapoulos, S, Ralston, S, Reiter, S, Werhya, G, Reginster, J
Published 2012Journal article -
19
Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study by Jonathan D. Adachi, Henry G. Bone, Nadia S. Daizadeh, Paula Dakin, Socrates Papapoulos, Peyman Hadji, Chris Recknor, Michael A. Bolognese, Andrea Wang, Celia J. F. Lin, Rachel B. Wagman, Serge Ferrari
Published 2017-04-01
Article -
20
Five-year denosumab treatment of postmenopausalwomen with osteoporosis: results of the first twoyears of the freedom trial extension. by S Papapoulos, Z Man, D Mellstrom, S Radominski, J-Y Reginster, H Resch, J Roman, S Roux, S Cummings, H Bone, R Chapurlar, M Brandi, J Brown, E Czerwinski, N Daizadeh, A Grauer, M-A Krieg, S Libanati
Published 2011-04-01
Article